Zest Dermatology

The holidays are just around the corner.  For those with #eczema and #psoriasis, we know this can be a stressful few weeks as you dedicate extra effort to your skin health. Zest is here to take away any added stress from your festive season.  We are looking for our first lucky eczema and/or psoriasis patients in #Pennsylvania or #Maryland to give feedback and try our new innovative virtual derm care platform for 45 days and at no charge!! As a beta partner, you would get: 1. Free and rapid access to a board-certified dermatologist (within 48 hours) 2. An integrative and personalized treatment plan 3. A certified health coach at your side with tools to help you make lifestyle interventions to sleep better, reduce stress and manage symptoms 4. Unlimited chat with our care team as needed  5. Prescription refills online from the comfort of your home Don't wait to get the personalized, holistic care and expertise you've been waiting for. Your participation and feedback will shape the platform and help transform the lives of millions suffering from psoriasis and eczema! Sign up today by sending us a message, commenting, or emailing hello@joinzest.com for the next steps. #maryland #pennsylvania #betatesting #eczema #psoriasis #skincare #dermatology #zestdermatology #zest #healthtech #healthcare #eczemastudy #psoriasisstudy

Exciting news for psoriasis treatment! A new study published in JAMA Dermatology supports Zest's approach to alternative at-home treatments like phototherapy. This randomized clinical trial of 783 patients found that home-based narrowband UV-B phototherapy for plaque or guttate psoriasis is just as effective as office-based treatments. Key findings include: (1) Noninferior patient and physician-reported outcomes (2) Reduced indirect costs for patients (3) Greater convenience and treatment adherence As a virtual dermatology clinic, Zest is proud to advocate for patient access to this safe and convenient in-home treatment for our #psoriasis and #eczema patients. Thanks to our DME partners Daavlin Phototherapy and NatBio, we're able to offer this proven treatment to patients in 47 states! Check out more at www.joinzest.com Joel M Gelfand MD MSCE

We are #hiring! Join our growing team at Zest Dermatology

We're excited that Zest’s Rachel Day MD, FAAD represented our company at the National Psoriasis Foundation’s Take Action event this past weekend! Zest and NPF share a vision for better access to timely care and higher quality care management for psoriasis patients. We’re also proud to be the only virtual clinic participating in the National Psoriasis Foundation's groundbreaking CP3 study, led by Joel M Gelfand MD MSCE. The CP3 study aims to improve the lives of those with psoriasis and psoriatic arthritis by focusing on preventing cardiovascular disease and mortality. At Zest, we’re committed to advancing the future of dermatology care and making a difference for patients with psoriatic disease. #ZestDermatology #psoriasis #arthritis #dermatology #PsoriaticDisease

In response to today's news regarding clinical trials of GLP-1s for use in psoriasis, Zest Dermatology's leadership shares the following insights:   Olivia Deitcher, CEO: "Psoriasis medications maintain strong formulary coverage despite high price tags. GLP-1 sponsors are clearly eyeing this market dynamic, perhaps to drive better coverage of their products. With our existing partners and beyond, Zest is well positioned to collaborate with health plans and employers to navigate the best path forward."   Rachel Day MD, FAAD, VP of Clinical: "As a dermatologist, I’m encouraged by the progress in understanding the systemic impact of psoriasis, including its links to cardiovascular disease and metabolic dysfunction. These conditions drive inflammation and contribute to overall health risks. However, I’m concerned that healthcare often prioritizes pharmaceutical solutions over lower-cost, effective interventions like diet and exercise, despite evidence supporting their benefits in psoriasis management. For instance, a 2014 randomized controlled study demonstrated significant improvement with a dietetic intervention and a recent review of nutrition as a therapeutic tool for psoriasis supported nutrition as a therapeutic intervention. I'll be closely following the emerging GLP-1 data."   Madison Muller Bloomberg News 📰 https://lnkd.in/g8uswP8X ⚕Study 1️⃣ | Naldi et al. (2014): Randomized controlled trial on diet and physical exercise in psoriasis ⚕Study 2️⃣ | Katsimbri et al. (2021): Review on nutrition as a therapeutic tool for psoriasis and psoriatic arthritis

Scientific research is the backbone of healthcare innovation. At Zest, we believe virtual care companies represent new frontiers for research collaboration. We are thrilled to announce our participation in the National Psoriasis Foundation’s CP3 study, proudly serving as the exclusive telehealth study site! The CP3 study investigates prevention of cardiovascular disease and mortality in patients with psoriasis or psoriatic arthritis. Individuals living with psoriatic disease face a shorter life expectancy, largely due to a heightened risk of cardiovascular disease (CVD) — including heart attacks and strokes. These patients often have undiagnosed and under-treated CVD risk factors such as high blood pressure and high cholesterol. CVD management drives high medical costs for health plans and employers, creating an opportunity to drive better outcomes at lower costs through care models like Zest. Thank you to Joel M Gelfand MD MSCE from University of Pennsylvania School of Medicine for including Zest on this study! We are proud to have Rachel Day MD, FAAD leading the efforts from the Zest side. Together, we are committed to advancing care and improving the lives of those affected by psoriatic disease. We are proud to be on the forefront of psoriasis care innovation. Learn more about the CP3 study here: (https://lnkd.in/grn-xdwN)

"For the past 25 years, I've tried everything. From the start, Zest takes a personalized approach and really listens!" - Sabrina, Psoriasis Patient & Advocate Effortless sign-up. Swift care. Lasting relief. www.joinzest.com